SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 150 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $155,000 | -4.3% | 26,725 | 0.0% | 0.00% | +33.3% |
| Q1 2016 | $162,000 | -33.6% | 26,725 | 0.0% | 0.00% | -40.0% |
| Q4 2015 | $244,000 | +61.6% | 26,725 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $151,000 | -49.0% | 26,725 | 0.0% | 0.00% | -40.0% |
| Q2 2015 | $296,000 | -29.4% | 26,725 | 0.0% | 0.01% | -28.6% |
| Q1 2015 | $419,000 | -38.1% | 26,725 | -40.0% | 0.01% | -36.4% |
| Q4 2014 | $677,000 | +30.7% | 44,525 | -7.2% | 0.01% | +22.2% |
| Q3 2014 | $518,000 | -53.4% | 48,005 | -34.1% | 0.01% | -52.6% |
| Q2 2014 | $1,112,000 | +28.0% | 72,805 | +51.5% | 0.02% | +26.7% |
| Q1 2014 | $869,000 | – | 48,055 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 1,400,000 | $12,320,000 | 4.56% |
| EcoR1 Capital, LLC | 2,568,119 | $22,599,000 | 4.01% |
| FIC CAPITAL INC | 960,338 | $8,451,000 | 3.48% |
| Opaleye Management Inc. | 580,000 | $5,104,000 | 2.13% |
| DAFNA Capital Management LLC | 225,000 | $1,980,000 | 1.41% |
| RA Capital Management | 1,250,000 | $11,000,000 | 1.26% |
| Iguana Healthcare Management, LLC | 215,000 | $1,892,000 | 1.07% |
| Avoro Capital Advisors LLC | 800,000 | $7,040,000 | 0.89% |
| WASATCH ADVISORS LP | 6,930,535 | $60,989,000 | 0.85% |
| Cormorant Asset Management, LP | 400,000 | $3,520,000 | 0.58% |